The Microbiome-Cancer Connection

The relationship between gut bacteria and cancer has moved from speculative to firmly evidence-based. The human gut microbiome influences cancer risk through at least four major pathways: chronic inflammation, immune system modulation, production of carcinogenic or protective metabolites, and direct genotoxic effects on host DNA. Understanding these mechanisms is not merely academic — it points to actionable strategies for reducing cancer risk through microbiome optimisation.

An estimated 20% of all cancers worldwide are attributable to infectious agents, and while viruses receive most attention, specific gut bacteria are now recognised as direct contributors to carcinogenesis in several cancer types.

How Gut Bacteria Promote or Prevent Cancer

Chronic Inflammation

Chronic, low-grade inflammation is a well-established cancer promoter. Gut dysbiosis drives systemic inflammation through increased intestinal permeability (allowing bacterial endotoxins to enter circulation), reduced production of anti-inflammatory short-chain fatty acids, and direct activation of pro-inflammatory signalling cascades including NF-kB and STAT3. These pathways promote cell proliferation, inhibit apoptosis, and create an environment conducive to malignant transformation.

Immune Surveillance

The gut microbiome trains and calibrates the immune system's ability to detect and destroy abnormal cells. A diverse, balanced microbiome supports robust natural killer (NK) cell activity, appropriate dendritic cell function, and effective cytotoxic T-cell responses — all critical components of anti-tumour immunity. When the microbiome is disrupted, immune surveillance weakens, allowing nascent cancer cells to escape detection.

Metabolite Production

Gut bacteria produce thousands of metabolites that reach systemic circulation. Some are protective:

  • Butyrate — inhibits histone deacetylase (HDAC), promoting apoptosis in cancer cells while protecting normal cells
  • Propionate — modulates immune cell function and has anti-proliferative effects
  • Urolithins — bacterial metabolites of ellagic acid (from berries and pomegranates) with anti-cancer properties

Others are harmful:

  • Secondary bile acids (deoxycholic acid, lithocholic acid) — produced when gut bacteria convert primary bile acids; at high concentrations, these are directly genotoxic and promote colorectal carcinogenesis
  • N-nitroso compounds — produced by certain bacteria from nitrates and amino acids; directly damage DNA
  • Hydrogen sulphide — at high concentrations, inhibits mitochondrial cytochrome c oxidase and promotes colonic cell proliferation
The balance between protective and harmful bacterial metabolites is largely determined by diet. A high-fibre, diverse plant-based diet favours protective metabolite production, while a high-fat, high-protein, low-fibre Western diet shifts the balance toward carcinogenic metabolites.

Direct Genotoxicity

Certain bacterial species produce toxins that directly damage host DNA. The most well-characterised example is colibactin, produced by certain strains of E. coli (specifically those carrying the pks genomic island). Colibactin causes double-strand DNA breaks and a specific mutational signature that has been identified in colorectal cancer genomes, providing direct evidence that this bacterial toxin contributes to cancer initiation.

Cancer Types Most Influenced by the Microbiome

While the microbiome may influence many cancer types, the strongest evidence exists for:

  • Colorectal cancer — the most extensively studied; specific bacterial species directly promote carcinogenesis
  • Gastric cancer — H. pylori is a WHO-classified Group 1 carcinogen responsible for the majority of gastric cancers
  • Hepatocellular carcinoma — gut-derived endotoxins reaching the liver through the portal vein promote hepatic inflammation and fibrosis that precedes cancer
  • Breast cancer — the estrobolome modulates circulating oestrogen levels, influencing hormone-receptor-positive breast cancer risk
  • Pancreatic cancer — emerging evidence links specific oral and gut bacteria to pancreatic cancer development

Reducing Cancer Risk Through Microbiome Health

Evidence-based strategies for optimising the microbiome to reduce cancer risk include:

  • Eat 30 or more different plant foods per week — dietary diversity is the strongest predictor of microbiome diversity
  • Prioritise high-fibre foods — aim for 30-40g of fibre daily from diverse sources to maximise SCFA production
  • Include daily fermented foods — to introduce beneficial bacteria and their metabolites
  • Limit red and processed meat — associated with increased secondary bile acid and N-nitroso compound production
  • Minimise alcohol consumption — alcohol disrupts the gut barrier, promotes dysbiosis, and is independently carcinogenic
  • Maintain a healthy weight — obesity-associated dysbiosis promotes chronic inflammation and alters oestrogen metabolism
  • Use antibiotics judiciously — each course of antibiotics disrupts the microbiome and may reduce long-term immune surveillance capacity

GutIQ helps you understand your current gut health status and identify areas where dietary and lifestyle modifications could support optimal microbiome function. While no single intervention guarantees cancer prevention, nurturing a diverse, balanced gut microbiome is one of the most evidence-supported strategies for reducing overall cancer risk.